Dr. Bartley Rust
America is facing one of the worst opioid use disorder (OUD) epidemics in modern times. The Comprehensive Addiction and Recovery Act allows advanced practitioner providers (APP) to obtain an x waiver by the Drug Enforcement Agency (DEA) to prescribe buprenorphine for medication-assisted treatment (MAT). Substance use disorder is a chronic relapsing disease requiring both medications and effective behavioral modification. Physician Assistants (PAs) and Nurse Practitioners (NPs) are uniquely trained and qualified to actively participate in addressing our national opioid healthcare crisis. Buprenorphine has experienced difficulty in expansion for maintenance due to reduced numbers of prescribers and failed to overtake methadone.
"The Role of Buprenorphine and Methadone in Opioid Use Disorder Harm Reduction,"
Lynchburg Journal of Medical Science: Vol. 1
, Article 7.
Available at: https://digitalshowcase.lynchburg.edu/dmscjournal/vol1/iss1/7
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.